In brief, obesity, characterized by chronic low-grade inflammation (elevated IL-6), increases hepcidin (an iron-regulating peptide hormone), reducing intestinal iron absorption, and eventually, leading to systemic iron deficiency and/or iron restricted erythropoiesis [32,36,37]. The gene discussed is IL6; the disease is obesity disorder.